During the past decade, Novum Instytut Dermatologii Leczniczej i Estetycznej conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Novum Instytut Dermatologii Leczniczej i Estetycznej" are "Psoriasis" (2 trials). Many other conditions were trialed in "Novum Instytut Dermatologii Leczniczej i Estetycznej" in a lesser frequency.

Most popular intervention types in "Novum Instytut Dermatologii Leczniczej i Estetycznej" are "Drug" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "CP 690,550 10 mg" (1 trials), "CP 690,550 5 mg" (1 trials), "CP-690,550" (1 trials), "Etanercept 50 mg" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Novum Instytut Dermatologii Leczniczej i Estetycznej" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Novum Instytut Dermatologii Leczniczej i Estetycznej". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Novum Instytut Dermatologii Leczniczej i Estetycznej, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Novum Instytut Dermatologii Leczniczej i Estetycznej, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".